Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 2Turcot syndrome 1Neoplasms 1Medulloblastoma 1Glioma 1Familial ependymoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

pembrolizumab 90Blood Specimen Collection 44Cyclophosphamide 37Nivolumab 35Bevacizumab 35Standard of Care 32Carboplatin 30Surveys and Questionnaires 29Paclitaxel 28atezolizumab 24Pemetrexed 24Gemcitabine 24Exercise 24Fluorouracil 23Cisplatin 23Leucovorin 21Dexamethasone 20Radiotherapy 19Oxaliplatin 19Docetaxel 19Rituximab 16Irinotecan 16Cetuximab 16dostarlimab 15Ipilimumab 15Doxorubicin 15Biopsy 15130-nm albumin-bound paclitaxel 15Drug Therapy 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Diffusion Tensor Imaging × 1 year × Clear all
NCT03208387 2025-09-12

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

Memorial Sloan Kettering Cancer Center

Active not recruiting
42 enrolled
CNS

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡